伊米达作为治疗抑郁症的血清素受体调节剂:结构洞察力和结构活动关系研究研究
Kapil Kumar Goel1, Somesh Thapliyal2, Rajeev Kharb3
1Department of Pharmaceutical Sciences, Gurukul Kangri (Deemed to Be University), Haridwar 249404, Uttarakhand, India.
研究人员探索了伊米达衍生物作为针对抑郁症治疗的新型抑制剂,以向血清激素系统. 这项研究详细介绍了它们的合成,结构性活动关系和抗抑郁药的潜力.
科学领域:
- 药用化学 医学化学
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 血清能信号传递对于抑郁症等精神疾病至关重要,使其成为关键的治疗点.
- 选择性血清素再吸收抑制剂 (SSRI) 和血清素-上腺素再吸收抑制剂 (SNRIs) 是通过调节神经递质水平的常见一线抑郁症治疗方法.
研究的目的:
- 为了研究以伊米达为基础的药解剂作为抗抑郁药开发的新型调节器的血清激素系统.
- 探索新型伊米达衍生物的合成,结构活性关系 (SAR) 和血清效应.
主要方法:
- 综述近期对意米达衍生物合成方法的进展.
- 对SAR研究的分析,重点是针对色素系统的基于伊米达的化合物.
- 对抗抑郁药活性新开发的伊米达衍生物的评估.
主要成果:
- 含有伊米达的药具有独特的结构和电子特性,有利于生物活性.
- 特定的修改和导化的伊米达支架显示在调节血清效的效果有前途.
- SAR研究提供了对抗抑郁药活性至关重要的结构特征的见解.
结论:
- 伊米达衍生物为开发新型抗抑郁药物提供了一个有前途的支架.
- 对基于伊米达的化合物的进一步研究可能会导致改善抑郁症治疗的血清激素系统调节器.
更多相关视频
08:49Rapid In Situ Hybridization using Oligonucleotide Probes on Paraformaldehyde-prefixed Brain of Rats with Serotonin Syndrome
Published on: September 23, 2015
07:30HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice
Published on: July 9, 2016
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
Antidepressant Drugs: Overview
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
